Up a level |
Bunn, Paul A., Jr., Minna, John D., Augustyn, Alexander, Gazdar, Adi F., Ouadah, Youcef, Krasnow, Mark A., Berns, Anton, Brambilla, Elisabeth, Rekhtman, Natasha, Massion, Pierre P., Niederst, Matthew, Peifer, Martin ORCID: 0000-0002-5243-5503, Yokota, Jun, Govindan, Ramaswamy, Poirier, John T., Byers, Lauren A., Wynes, Murry W., McFadden, David G., MacPherson, David ORCID: 0000-0003-3729-907X, Hann, Christine L., Farago, Anna F., Dive, Caroline ORCID: 0000-0002-1726-8850, Teicher, Beverly A., Peacock, Craig D., Johnson, Jane E., Cobb, Melanie H., Wendel, Hans -Guido, Spigel, David, Sage, Julien, Yang, Ping, Pietanza, M. Catherine, Krug, Lee M., Heymach, John, Ujhazy, Peter, Zhou, Caicun, Goto, Koichi, Dowlati, Afshin, Christensen, Camilla Laulund, Park, Keunchil, Einhorn, Lawrence H., Edelman, Martin J., Giaccone, Giuseppe ORCID: 0000-0002-5023-7562, Gerber, David E., Salgia, Ravi, Owonikoko, Taofeek, Malik, Shakun, Karachaliou, Niki, Gandara, David R., Slotman, Ben J., Blackhall, Fiona ORCID: 0000-0001-8716-3395, Goss, Glenwood, Thomas, Roman, Rudin, Charles M. and Hirsch, Fred R. (2016). Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes? J. Thorac. Oncol., 11 (4). S. 453 - 475. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Doebele, Robert C., Dziadziuszko, Rafal, Drilon, Alexander, Shaw, Alice T., Wolf, Juergen, Farago, Anna F., Dennis, Lucas, Riehl, Todd, Simmons, Brian, Wu, Charlie, Chang, Ching-Wei, Choeurng, Voleak and Wilson, Timothy R. (2020). Genomic Landscape of Entrectinib Resistance from Circulating Tumor DNA (CTDNA) Analysis in STARTRK-2. Oncol. Res. Treat., 43. S. 217 - 218. BASEL: KARGER. ISSN 2296-5262
Drapkin, Benjamin J., George, Julie, Christensen, Camilla L., Mino-Kenudson, Mari, Dries, Ruben ORCID: 0000-0001-7650-7754, Sundaresan, Tilak, Phat, Sarah, Myers, David T., Zhong, Jun, Igo, Peter, Hazar-Rethinam, Mehlika H., Licausi, Joseph A., Gomez-Caraballo, Maria, Kem, Marina, Jani, Kandarp N., Azimi, Roxana, Abedpour, Nima, Menon, Roopika, Lakis, Sotirios, Heist, Rebecca S., Buettner, Reinhard, Haas, Stefan ORCID: 0000-0003-3418-3688, Sequist, Lecia V., Shaw, Alice T., Wong, Kwok-Kin, Hata, Aaron N., Toner, Mehmet, Maheswaran, Shyamala, Haber, Daniel A., Peifer, Martin, Dyson, Nicholas, Thomas, Roman K. and Farago, Anna F. (2018). Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts. Cancer Discov., 8 (5). S. 600 - 616. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2159-8290
Drapkin, Benjamin J., George, Julie, Stanzione, Marcello, Yeap, Beow Y., Mino-Kenudson, Mari, Christensen, Camilla L., Dries, Ruben, Phat, Sarah, Zhong, Jun, Myers, David T., Licausi, Joseph A., Sundaresan, Tilak, Kem, Marina, Abedpour, Nima, Sequist, Leica V., Shaw, Alice T., Hata, Aaron N., Toner, Mehmet, Maheswaran, Shyamala, Haber, Daniel A., Peifer, Martin, Thomas, Roman K., Farago, Anna F. and Dyson, Nicholas J. (2018). Co-clinical trial of olaparib and temozolomide in SCLC PDX models uncovers new biomarkers of sensitivity. Cancer Res., 78 (13). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Morgensztern, Daniel, Besse, Benjamin, Greillier, Laurent ORCID: 0000-0002-5807-9503, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Farago, Anna F., Dowlati, Afshin, Rudin, Charles M., Le Moulec, Sylvestre, Lally, Satwant, Yalamanchili, Sreeni, Wolf, Juergen, Govindan, Ramaswamy and Carbone, David P. (2019). Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study. Clin. Cancer Res., 25 (23). S. 6958 - 6967. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265
Paz-Ares, Luis, Dziadziuszko, Rafal, Drilon, Alexander, John, Thomas, Krebs, Matthew, Demetri, George, Shaw, Alice T., Siena, Salvatore, Wolf, Juergen, Farago, Anna F., Simmons, Brian, Pitcher, Bethany, Huang, Xinhui and Doebele, Robert (2020). Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors or ROS1-Positive NSCLC with CNS Metastases. Oncol. Res. Treat., 43. S. 235 - 236. BASEL: KARGER. ISSN 2296-5262